SynthesisMedicine2019

Adverse drug events associated with ibrutinib for the treatment of elderly patients with chronic lymphocytic leukemia: A systematic review and meta-analysis of randomized trials.

Yanhua Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.